Previous studies have demonstrated that the upregulation of ARPC5 can be found in a variety of tumors, such as head and neck squamous cell carcinoma and multiple myeloma, in agreement with our observational results [22, 23]. This evidence concerns the gene ARPC5 and plasma cell myeloma.